Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 10757833

Stroke treatment-specific considerations.

S E Kasner
View original source ↗Export metadata ↓

Abstract

Unusual causes of stroke account for a minority of all strokes, but they have specific diagnostic and therapeutic implications which must be considered early in the clinical course. This article focuses on arteriopathies such as arterial dissection, vasospasm-induced stroke, and vasculitis; hematological disorders such as hypercoagulable states, disseminated intravascular coagulation, and sickle cell disease; migraine-induced stroke, and cerebral venous thrombosis.

Explore related subjects

Cerebral AngiographyDiagnosis, DifferentialHumansMagnetic Resonance ImagingSinus Thrombosis, IntracranialStrokeJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S E Kasner. 2000. Stroke treatment-specific considerations.. https://doi.org/10.1016/s0733-8619(05)70199-7

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2003

Ultra-early hemostatic therapy for intracerebral hemorrhage.

BACKGROUND: Intracerebral hemorrhage (ICH) causes higher morbidity and mortality than other forms of stroke and has no proven effective treatment. Hematoma volume is a powerful predictor of outcome after ICH. SUMMARY OF REVIEW: Historically, ICH bleeding was considered to be a monophasic event that stopped quickly as a result of clotting and tamponade by surrounding brain tissue. More recently, prospective and retrospective CT-based studies have demonstrated that hematoma growth occurs in up to 38% of patients initially scanned within 3 hours of onset and in 16% scanned between 3 and 6 hours, even in the absence of coagulopathy. Progressive bleeding of this type has been associated with contrast extravasation on CT angiography and poor outcome after early (<4 hours) surgical clot evacuation. On the basis of these observations, it is plausible that ultra-early hemostatic therapy given in the emergency setting might reduce ICH volume in some patients and improve outcome. Among candidate agents for this indication, the most promising is recombinant activated factor VIIa, which promotes local hemostasis at sites of vascular injury in both coagulopathic and normal patients. CONCLUSIONS: Ultra-early hemostatic therapy, given within 3 to 4 hours of onset, may potentially arrest ongoing bleeding and minimize hematoma growth after ICH. Given the current lack of effective therapy for ICH, clinical trials testing this treatment approach are justified.

Cerebral Angiography↗
PubMed2003

Development of multiple cerebral arteriovenous malformations documented in an adult by serial angiography. Case report.

A 50-year-old woman with a parietal intracerebral hematoma was initially treated by hematoma evacuation. Initial preoperative and follow-up angiograms obtained 6 months later demonstrated no pial arteriovenous malformations (AVMs). She suffered a subarachnoid hemorrhage 8 years later. Results of follow-up cerebral angiography revealed the development of previously undetected multiple cerebral AVMs. This appears to be the first reported case of the development of multiple cerebral AVMs in an adult, demonstrated on serial angiography.

Cerebral Angiography↗